QNTM
QNTM
NASDAQ · Pharmaceuticals

Quantum Biopharma-B Sub Vot

$4.71
-0.02 (-0.42%)
As of Mar 25, 5:20 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +101.3% upside
Low Target $6.03
Average Target $9.48
High Target $10.62
Current Price $4.71
Current
$4.71
Target
$9.48
$6.03 $9.48 avg $10.62
Scenario Analysis
Bear Case
$6.03
28.0%
Low target
Base Case
$9.48
+101.3%
Avg target
Bull Case
$10.62
+125.5%
High target
Risk/Reward
4.5x
Highly favorable
Price in Context
52-Week High
$52.00
-90.9% from high
52-Week Low
$2.85
+65.3% from low
Target vs 52W High
$9.48
-81.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%